Agilent Technologies (A) vs IDEXX Laboratories (IDXX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Agilent Technologies (A) has outperformed IDEXX Laboratories (IDXX) over the past year, gaining 22.0% versus a loss of 19.3%. Over five years, A leads with a +10.3% price change compared with -20.3% for IDXX. Agilent Technologies is the larger company by market cap ($47.68 billion vs $39.92 billion), about 1.2 times the size, while IDEXX Laboratories is growing revenue faster (+10.4% vs +6.7%).
On valuation, Agilent Technologies trades at a lower forward P/E (25.0x vs 30.3x for IDEXX Laboratories). Agilent Technologies pays a dividend yielding 0.60%, while IDEXX Laboratories does not currently pay one. IDEXX Laboratories converts more of its revenue into profit, with a net margin of 24.6% versus 18.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | IDXX |
|---|---|---|
| Share price | $169.09 | $506.67 |
| Market cap | $47.68B | $39.92B |
| 1-day change | -0.14% | -1.70% |
| YTD return | +24.28% | -25.21% |
| 1-year return | +22.05% | -19.34% |
| 5-year return | +10.33% | -20.34% |
| P/E ratio (TTM) | 33.35 | 36.40 |
| Forward P/E | 25.02 | 30.27 |
| EPS (TTM) | $5.07 | $13.92 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $1.01 | $0.00 |
| Revenue (latest FY) | $6.95B | $4.30B |
| Revenue growth (YoY) | +6.73% | +10.42% |
| Net income (latest FY) | $1.30B | $1.06B |
| Gross margin | 52.43% | 61.80% |
| Operating margin | 21.29% | 31.60% |
| Net margin | 18.75% | 24.62% |
| 52-week high | $177.05 | $769.98 |
| 52-week low | $108.35 | $500.61 |
| Distance from 52-week high | -4.50% | -34.20% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +4.38% | +38.42% |
| Average volume | 2.26M | 556.43K |
| Shares outstanding | 281.97M | 78.78M |
| Employees | 18,200 | 11,000 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- A has outperformed IDXX by 41.4 percentage points over the past year.
- IDEXX Laboratories is more profitable, keeping 24.6 cents of every revenue dollar as net income versus 18.8 cents for Agilent Technologies.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Healthcare · Diagnostics & Research · 18,200 employees
About IDEXX Laboratories
IDXX stock →IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Healthcare · Diagnostics & Research · 11,000 employees
A vs IDXX FAQ
Which is bigger, Agilent Technologies or IDEXX Laboratories?
Agilent Technologies (A) is larger, with a market capitalization of $47.68B compared with $39.92B for IDEXX Laboratories (IDXX).
Which stock has performed better over the past year, A or IDXX?
A returned +22.05% over the past 12 months, compared with -19.34% for IDXX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or IDXX?
A has the lower trailing P/E at 33.4, versus 36.4 for IDXX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or IDEXX Laboratories?
Agilent Technologies pays a dividend yielding 0.60%, while IDEXX Laboratories does not currently pay a regular dividend.
Are Agilent Technologies and IDEXX Laboratories in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.